Regulatory actions to enhance appropriate drug use: The case of antidiarrhoeal drugs
- 30 April 1996
- journal article
- research article
- Published by Elsevier in Social Science & Medicine
- Vol. 42 (7) , 1011-1019
- https://doi.org/10.1016/0277-9536(95)00212-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Examining product risk in context. Market withdrawal of zomepirac as a case studyJAMA, 1993
- Management of acute diarrhea in childrenThe Pediatric Infectious Disease Journal, 1993
- Effects of Professional and Media Warnings about the Association between Aspirin Use in Children and Reye's SyndromeThe Milbank Quarterly, 1992
- Management of childhood diarrhoea by pharmacists and parents: is Britain lagging behind the Third World?BMJ, 1991
- Rational Drug Use: An Unsolved ProblemTropical Doctor, 1990
- Loperamide poisoning in childrenThe Lancet, 1990
- Withdrawing payment for nonscientific drug therapy. Intended and unexpected effects of a large-scale natural experimentJAMA, 1990
- Ridding the world of hydroxyquinolines.BMJ, 1989
- Effect of government and commercial warnings on reducing prescription misuse: the case of propoxyphene.American Journal of Public Health, 1987